Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)
Stock Information for Dicerna Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.